Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	69.53	66.39	59.97	142.75	28.38
Short-Term Investments	188.39	270.5	306.17	342.51	161.94
Cash & Short-Term Investments	257.92	336.89	366.13	485.26	190.32
Cash Growth	-23.44%	-7.99%	-24.55%	154.97%	370.80%
Receivables	-	-	2	2	2
Prepaid Expenses	8.43	8.8	6.57	4.52	1.31
Restricted Cash	-	0.86	0.57	0.57	-
Total Current Assets	266.34	346.54	375.27	492.34	193.63
Property, Plant & Equipment	47.58	53.42	57.77	6.09	11.3
Other Long-Term Assets	2.57	2.61	3.43	1.73	2.32
Total Assets	316.49	402.57	436.47	500.16	207.25
Accounts Payable	1.6	2.79	4.45	3.23	1.84
Accrued Expenses	14.76	14.11	16.23	9.22	5.35
Current Portion of Leases	2.45	2.08	1.77	1.5	0.96
Current Income Taxes Payable	-	-	0.04	0.05	-
Current Unearned Revenue	17.62	25.67	31.79	26.02	31.98
Other Current Liabilities	1.74	1.29	1.27	0.67	0.79
Total Current Liabilities	38.17	45.94	55.55	40.69	40.92
Long-Term Leases	34.04	36.84	39.36	-	6.93
Long-Term Unearned Revenue	44.77	66.68	92.09	114.72	120.81
Other Long-Term Liabilities	-	-	-	-	0.01
Total Liabilities	116.98	149.46	186.99	155.41	168.65
Common Stock	0.11	0.1	0.09	0.09	0.04
Additional Paid-In Capital	700.63	624.08	522.61	506.76	141.64
Retained Earnings	-501.56	-371.26	-269.51	-161.34	-103.1
Comprehensive Income & Other	0.34	0.19	-3.71	-0.77	0.02
Total Common Equity	199.52	253.11	249.48	344.75	38.6
Shareholders' Equity	199.52	253.11	249.48	344.75	38.6
Total Liabilities & Equity	316.49	402.57	436.47	500.16	207.25
Total Debt	36.49	38.92	41.13	1.5	7.88
Net Cash (Debt)	221.42	297.97	325	483.75	182.44
Net Cash Growth	-25.69%	-8.32%	-32.82%	165.16%	472.15%
Net Cash Per Share	2.03	3.15	3.70	7.79	5.71
Filing Date Shares Outstanding	108.11	106.72	88.2	87.71	14.2
Total Common Shares Outstanding	107.73	102.2	88.18	87.6	13.3
Working Capital	228.17	300.6	319.73	451.65	152.72
Book Value Per Share	1.85	2.48	2.83	3.94	2.90
Tangible Book Value	199.52	253.11	249.48	344.75	38.6
Tangible Book Value Per Share	1.85	2.48	2.83	3.94	2.90
Machinery	13.32	12.88	11.65	6.25	5.14
Construction In Progress	0.15	0.04	0.01	0.74	-
Leasehold Improvements	2.87	2.86	2.78	0.25	0.25

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q